These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 27084050
1. Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance. Chen H, Xiong Z, Liu K, Li S, Wang R, Wang X, Zhang Y, Wang H. Int J Antimicrob Agents; 2016 May; 47(5):362-7. PubMed ID: 27084050 [Abstract] [Full Text] [Related]
2. VraSR has an important role in immune evasion of Staphylococcus aureus with low level vancomycin resistance. Gao C, Dai Y, Chang W, Fang C, Wang Z, Ma X. Microbes Infect; 2019 May; 21(8-9):361-367. PubMed ID: 31009806 [Abstract] [Full Text] [Related]
3. The Vancomycin Resistance-Associated Regulatory System VraSR Modulates Biofilm Formation of Staphylococcus epidermidis in an ica-Dependent Manner. Wu Y, Meng Y, Qian L, Ding B, Han H, Chen H, Bai L, Qu D, Wu Y. mSphere; 2021 Oct 27; 6(5):e0064121. PubMed ID: 34550006 [Abstract] [Full Text] [Related]
4. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus. Katayama Y, Sekine M, Hishinuma T, Aiba Y, Hiramatsu K. Antimicrob Agents Chemother; 2016 Jun 27; 60(6):3730-42. PubMed ID: 27067329 [Abstract] [Full Text] [Related]
5. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. Howden BP, Smith DJ, Mansell A, Johnson PD, Ward PB, Stinear TP, Davies JK. BMC Microbiol; 2008 Feb 27; 8():39. PubMed ID: 18304359 [Abstract] [Full Text] [Related]
6. Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem. Katayama Y, Murakami-Kuroda H, Cui L, Hiramatsu K. Antimicrob Agents Chemother; 2009 Aug 27; 53(8):3190-6. PubMed ID: 19451283 [Abstract] [Full Text] [Related]
7. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. Mol Microbiol; 2003 Aug 27; 49(3):807-21. PubMed ID: 12864861 [Abstract] [Full Text] [Related]
8. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300. Gardete S, Kim C, Hartmann BM, Mwangi M, Roux CM, Dunman PM, Chambers HF, Tomasz A. PLoS Pathog; 2012 Feb 27; 8(2):e1002505. PubMed ID: 22319446 [Abstract] [Full Text] [Related]
9. VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA. Dai Y, Chang W, Zhao C, Peng J, Xu L, Lu H, Zhou S, Ma X. Antimicrob Agents Chemother; 2017 May 27; 61(5):. PubMed ID: 28289032 [Abstract] [Full Text] [Related]
10. Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, Hiramatsu K. Antimicrob Agents Chemother; 2011 Sep 27; 55(9):4188-95. PubMed ID: 21746940 [Abstract] [Full Text] [Related]
11. Epigallocatechin gallate induces upregulation of the two-component VraSR system by evoking a cell wall stress response in Staphylococcus aureus. Levinger O, Bikels-Goshen T, Landau E, Fichman M, Shapira R. Appl Environ Microbiol; 2012 Nov 27; 78(22):7954-9. PubMed ID: 22941085 [Abstract] [Full Text] [Related]
12. Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus. Yoo JI, Kim JW, Kang GS, Kim HS, Yoo JS, Lee YS. J Microbiol; 2013 Apr 27; 51(2):160-5. PubMed ID: 23625215 [Abstract] [Full Text] [Related]
14. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS. Berscheid A, François P, Strittmatter A, Gottschalk G, Schrenzel J, Sass P, Bierbaum G. J Antimicrob Chemother; 2014 Dec 27; 69(12):3190-8. PubMed ID: 25103491 [Abstract] [Full Text] [Related]
16. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus. Cui L, Lian JQ, Neoh HM, Reyes E, Hiramatsu K. Antimicrob Agents Chemother; 2005 Aug 27; 49(8):3404-13. PubMed ID: 16048954 [Abstract] [Full Text] [Related]
17. Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR. Kato Y, Suzuki T, Ida T, Maebashi K. J Antimicrob Chemother; 2010 Jan 27; 65(1):37-45. PubMed ID: 19889788 [Abstract] [Full Text] [Related]
18. Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Cui L, Neoh HM, Shoji M, Hiramatsu K. Antimicrob Agents Chemother; 2009 Mar 27; 53(3):1231-4. PubMed ID: 19124662 [Abstract] [Full Text] [Related]
19. Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus. Gardete S, Wu SW, Gill S, Tomasz A. Antimicrob Agents Chemother; 2006 Oct 27; 50(10):3424-34. PubMed ID: 17005825 [Abstract] [Full Text] [Related]
20. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus. Shoji M, Cui L, Iizuka R, Komoto A, Neoh HM, Watanabe Y, Hishinuma T, Hiramatsu K. Antimicrob Agents Chemother; 2011 Aug 27; 55(8):3870-81. PubMed ID: 21628539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]